In vitro comparison of the effect of inhalation delay on the variability of the delivered dose from valved holding chambers

D. Von Hollen, P. Hancock, R. Hatley, K. Nikander (Parsippany, United States Of America; Chichester, United Kingdom)

Source: Annual Congress 2012 - Assessing and treating childhood asthma and allergy
Session: Assessing and treating childhood asthma and allergy
Session type: Thematic Poster Session
Number: 4104
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Von Hollen, P. Hancock, R. Hatley, K. Nikander (Parsippany, United States Of America; Chichester, United Kingdom). In vitro comparison of the effect of inhalation delay on the variability of the delivered dose from valved holding chambers. Eur Respir J 2012; 40: Suppl. 56, 4104

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Antistatic treatment and the amount of salbutamol actuated have variable effect on drug delivery of six different valved holding chambers (VHC)
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019

In vitro delivery of an HFA-based corticosteroid by pediatric and adult valved holding chambers (VHC): effect of inhalation flow rate
Source: Eur Respir J 2002; 20: Suppl. 38, 500s
Year: 2002

Breath-by-breath delivered dose comparison from three anti-static valved holding chambers with facemasks under simulated pediatric breathing conditions
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011

Impact of inspiratory delay and valved holding chamber (VHC) material on drug delivery
Source: Eur Respir J 2001; 18: Suppl. 33, 494s
Year: 2001

Not all antistatic valved holding chambers have equivalent performance: An example why each valved holding chamber (VHC)-inhaler combination should be considered unique
Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs
Year: 2012


Delivery of medication via a novel non-electrostatic valved holding chamber (VHC) for infant use depends on the number of inhalations
Source: Eur Respir J 2006; 28: Suppl. 50, 713s
Year: 2006

The impact of different valved holding chambers (VHCs) on lung drug delivery: using functional respiratory imaging (FRI) and a single metered dose inhaler (MDI) type
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020




A visual indicator for inhalation from a valved holding chamber (VHC) is an aid in delivery of inhaled medication to infants and small children via facemask
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009


Priming of a non-conducting valved holding chamber (VHC) is formulation dependent and may result in inconsistent medication delivery
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007


Evaluation of delivered dose and treatment time of several mesh nebulizers under in vitro simulated use
Source: International Congress 2017 – Inhalers and their use
Year: 2017

Are there differences in throat deposition using variable valved holding chambers (VHC)?
Source: Eur Respir J 2006; 28: Suppl. 50, 713s
Year: 2006

Comparison of two valved holding chambers for the delivery of an HFA-based solution corticosteroid formulation
Source: Eur Respir J 2002; 20: Suppl. 38, 500s
Year: 2002

Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019

Effect of changes in peak inspiratory flow on the dose of salbutamol delivered by nebulizers under simulated conditions
Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD?
Year: 2018




Inhaled corticosteroid fine particle dose from valved holding chambers
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010


Valved holding chambers vary considerably in drug delivery efficacy
Source: International Congress 2018 – Paediatric asthma: prevention, diagnosis and treatment
Year: 2018




Laboratory assessment of drug delivery of Beclomethasone/Formoterol metered dose inhaler (MDI) with a new valved holding chamber (VHC) designed specifically for 'on-the-go' use.
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021


A small volume valved holding chamber (VHC) manufactured from charge dissipative materials has comparable in vitro performance with a large volume non-conducting plastic spacer for both bronchodilator and anti-inflammatory formulations
Source: Eur Respir J 2005; 26: Suppl. 49, 340s
Year: 2005

Feedback during treatment results in increased adherence when using a pressurized metered dose inhaler with valved holding chamber in paediatric patients with asthma
Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children
Year: 2008

Valved holding chamber drug delivery is dependent on breathing pattern and device design
Source: ERJ Open Res, 5 (1) 00158-2018; 10.1183/23120541.00158-2018
Year: 2019